Clinical Trials Logo

Pathological Gambling clinical trials

View clinical trials related to Pathological Gambling.

Filter by:

NCT ID: NCT00203645 Completed - Clinical trials for Pathological Gambling

Minimal and Brief Treatments for Pathological Gamblers

Start date: July 2003
Phase: Phase 3
Study type: Interventional

The purpose of the study is to examine whether problem gamblers who receive therapy calls in addition to a self-help manual will be more likely to quit or cut back on their gambling when compared with problem gamblers who receive just the manual.

NCT ID: NCT00132119 Completed - Clinical trials for Pathological Gambling

Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling

Start date: August 2005
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine if nalmefene is safe and effective in the treatment of pathological gambling.

NCT ID: NCT00078273 Completed - Clinical trials for Pathological Gambling

Indicated Prevention With At-Risk Gamblers

Start date: July 2003
Phase: Phase 2
Study type: Interventional

The overall purpose of this study is to reduce the prevalence of gambling risk in college students by evaluating the effectiveness of different treatments in reducing gambling behavior and related negative consequences.

NCT ID: NCT00055393 Completed - Clinical trials for Pathological Gambling

Bupropion in the Treatment of Pathological Gambling

Start date: July 2002
Phase: N/A
Study type: Interventional

This study will determine whether the drug bupropion is an effective treatment for Pathological Gambling.